sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-May-2016 06:05
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 976-1000 out of 1244.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

Public Release: 12-Nov-2014
Science Translational Medicine
New scientific review reveals huge gaps in understanding preterm birth
Preterm birth is now the leading cause of death for children under 5 worldwide, and a new scientific paper reveals a startling lack of knowledge about what causes it and how to prevent it.
Global Alliance to Prevent Prematurity and Stillbirth

Contact: Casey Calamusa
Seattle Children's

Public Release: 12-Nov-2014
Journal of Hypertension
High blood pressure puts 1 in 4 Nigerians at risk, study says
High blood pressure -- already a massive hidden killer in Nigeria -- is set to sharply rise as the country adopts western lifestyles, a University of Edinburgh study suggests.

Contact: Andrew Moffat
University of Edinburgh

Public Release: 12-Nov-2014
Science Translational Medicine
Semen directly impairs effectiveness of microbicides that target HIV
Researchers from the Gladstone Institutes and the University of Ulm have discovered why microbicides developed to prevent HIV succeed in the lab but fail in clinical trials: Semen. Semen enhances the infectiousness of HIV by causing the virus to cluster together, increasing its ability to attach to and infect cells. This effect is then sufficient to override the antiviral properties of the microbicides.
Deutsche Forschungsgemeinschaft, Ministerium-Wissenschaft, Forschung und Kunst, Baden-Württemberg, National Institutes of Health, NIH/National Institutes of Allergy and Infectious Diseases, European Research Council

Contact: Dana Smith
Gladstone Institutes

Public Release: 11-Nov-2014
QUT helps China to better predict dengue fever outbreaks
Queensland University of Technology researchers have found the habit of Googling for an online diagnosis before visiting the doctor can be a powerful predictor of infectious diseases outbreaks. Now studies by the same Brisbane-based researchers show combining information from monitoring internet search metrics such as Baidu (China's equivalent of Google), with a web-based infectious disease alert system from reported cases and environmental factors hold the key to improving early warning systems and reducing the deadly effects of dengue fever in China.

Contact: Sandra Hutchinson
Queensland University of Technology

Public Release: 11-Nov-2014
Infectious diseases researcher wins $1.225 million fellowship
Dr. Marc Pellegrini is one of three researchers to this year be awarded a 2014 Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship.
Sylvia and Charles Viertel Charitable Foundation

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 11-Nov-2014
Nature Genetics
Mapping the spread of diarrhea bacteria a major step towards new vaccine
Every year hundreds of thousands of people die from diarrheal diseases caused by ETEC bacteria. A study published in Nature Genetics describes how Swedish researchers have mapped the spread of strains of ETEC bacteria around the world. It provides key information about how pathogenic bacteria arise, which will be important for the Swedish diarrhea vaccine currently under development.

Contact: Astrid von Mentzer
University of Gothenburg

Public Release: 11-Nov-2014
PLOS Medicine
New therapy for trauma survivors
A newly developed transdiagnostic psychotherapy, called the Common Elements Treatment Approach, is effective for reducing mental health symptoms among Burmese trauma survivors living in Thailand, according to a study published by Paul Bolton and colleagues from Johns Hopkins Bloomberg School of Public Health and University of Washington, USA in this week's PLOS Medicine.
United States Agency for International Development Victims of Torture Fund

Contact: Maya Sandler

Public Release: 10-Nov-2014
University of Toronto launches search for new Ebola drug using artificial intelligence
The University of Toronto, Chematria and IBM are combining forces in a quest to find new treatments for the Ebola virus. Using a virtual research technology invented by Chematria, a startup housed at U of T's Impact Centre, the team will use software that learns and thinks like a human chemist to search for new medicines.

Contact: Michael Kennedy
University of Toronto

Public Release: 10-Nov-2014
Nursing Standard
The University of Huddersfield leads research and teaching into spirituality in health care
The term 'spirituality' is now widely used to describe the qualities that give people hope, meaning and purpose. In the case of patients, it can aid their recovery. Articles, overseas conference presentations and now close links with an NHS trust are among the recent outputs and activities of the university's Spirituality Special Interest Group, based in the School of Human and Heath Sciences.

Contact: Nicola Werritt
University of Huddersfield

Public Release: 10-Nov-2014
JAMA Pediatrics
Overall risk of birth defects appears low for women taking antiretrovirals during early pregnancy
Among pregnant women infected with HIV, the use of antiretroviral medications early in pregnancy to treat their HIV or to prevent mother-to-child transmission of HIV does not appear to increase the risk of birth defects in their infants, according to a new study led by Harvard School of Public Health.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development,NIH/National Institute on Drug Abuse, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institute of Mental Health, and others

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 9-Nov-2014
Quest for hepatitis B treatment wins Emerging Researcher Award
Walter and Eliza Hall Institute researcher Dr. Greg Ebert has won the Bupa Health Foundation Emerging Health Researcher Award 2014 for his work on developing a new therapy for chronic hepatitis B virus infection.
Bupa Health Foundation

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 9-Nov-2014
Ben-Gurion U. Prof. Zvi Bentwich receives Bill & Melinda Gates Foundation grant
The funding will help support mass drug eradication efforts against these infections by implementing in parallel a health education campaign run by local students with the provision of clean water and sanitation facilities. Behavioral change and hygiene are essential for the eradication of many diseases.
Bill and Melinda Gates Foundation

Contact: Andrew Lavin
American Associates, Ben-Gurion University of the Negev

Public Release: 6-Nov-2014
World War I soldier helps in fight against dysentery
Research into a bacterial sample from World War I has revealed secrets of the dysentery-causing strain's success and uncovered the story of the soldier behind the sample.
Wellcome Trust

Contact: Mary Clarke
Wellcome Trust Sanger Institute

Public Release: 4-Nov-2014
Proceedings of the National Academy of Sciences
How important is long-distance travel in the spread of epidemics?
When modeling the spread of epidemics, such as the Ebola outbreak, scientists must take into account the long-distance hops now possible with international air travel. But how important are such long-distance jumps? A new model by biophysicists Oskar Hallatschek of UC Berkeley and Daniel Fisher of Stanford shows that how common long-range jumps are makes a big difference in the dispersal of a disease, that is, whether you get slow, rippling versus rapid metastatic spread.
Simons Foundation, National Science Foundation

Contact: Robert Sanders
University of California - Berkeley

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
ASMQ FDC proves safe and efficacious to treat children in Africa with malaria
Presented today at the 63rd annual meeting of the American Society of Tropical Medicine and Hygiene, results of a multi-centre clinical trial in Africa, launched in 2008, to test the efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination in children under 5 years of age with uncomplicated falciparum malaria showed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine FDC -- Africa's most widely adopted treatment.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 4-Nov-2014
Ebola, Marburg viruses edit genetic material during infection
Filoviruses like Ebola 'edit' genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology. The work, by researchers at the Icahn School of Medicine at Mount Sinai, the Galveston National Laboratory, and the J. Craig Venter Institute, could lead to a better understanding of these viruses, paving the way for new treatments down the road.
National Institutes of Health, J. Craig Venter Institute

Contact: Garth Hogan
American Society for Microbiology

Public Release: 4-Nov-2014
PLOS Medicine
Preventing postpartum hemorrhage
Sublingual misoprostol is inferior to intramuscular oxytocin for the prevention of postpartum hemorrhage (PPH) in women undergoing uncomplicated birth at a regional hospital in Uganda, according to trial results published in PLOS Medicine. The randomized non-inferiority trial, conducted by Esther Cathyln Atukunda at the Mbarara University of Science and Technology, Uganda, and colleagues, showed that PPH incidence in the misoprostol arm exceeded that in the oxytocin arm by 11.2 percent.
Father Bash Foundation, Divine Mercy Hospital

Contact: Maya Sandler

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
American Journal of Tropical Medicine and Hygiene
New research: Undiagnosed, undertreated Chagas disease emerging as US public health threat
Across a broad swath of the southern United States, residents face a tangible but mostly unrecognized risk of contracting Chagas disease -- a stealthy parasitic infection that can lead to severe heart disease and death -- according to new research presented today at the American Society of Tropical Medicine and Hygiene Annual Meeting.

Contact: Bridget DeSimone

Public Release: 4-Nov-2014
ASTMH 63rd Annual Meeting
New study: Forensic DNA test conclusively links snake bite marks on people to species
Starting with a simple DNA swab taken from fang marks on people bitten by snakes, an international research team correctly identified the species of the biting snake 100 percent of the time in a first-of-its-kind clinical study, according to data presented today at the American Society of Tropical Medicine and Hygiene's (ASTMH) Annual Meeting.

Contact: Preeti Singh

Public Release: 3-Nov-2014
AAPS Annual Meeting and Exposition
Nasal spray vaccine has potential for long-lasting protection from Ebola virus
A nasal vaccine in development by researchers at the University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus.

Contact: Amanda Johnson
American Association of Pharmaceutical Scientists

Public Release: 3-Nov-2014
ASTMH 63rd Annual Meeting
Malaria from monkeys now dominant cause of human malaria hospitalizations in Malaysia
The majority of malaria hospitalizations in Malaysia are now caused by a dangerous and potentially deadly monkey-borne parasite once rarely seen in humans, and deforestation is the potential culprit in a growing number of infections that could allow this virulent malaria strain to jump from macaque monkeys to human hosts, according to research presented today at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting.

Contact: Preeti Singh

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New malaria vaccines to prevent infection and block transmission get a shot in the arm
In support of a bold quest to rid the world entirely of malaria, the Bill & Melinda Gates Foundation today announced an award of US$156 million to PATH to support the PATH Malaria Vaccine Initiative in building new vaccines that will interrupt the cycle of malaria parasite transmission and help realize the 'accelerating to zero' agenda. Such vaccines would ensure that parasite reintroduction is prevented by providing what could be called an 'immunological bed net.'
Bill & Melinda Gates Foundation

Contact: Kelsey Mertes
PATH Malaria Vaccine Initiative (MVI)

Public Release: 2-Nov-2014
ASTMH 63rd Annual Meeting
New test will combat major cause of preventable blindness in Africa
PATH, an international nonprofit organization, announces the availability of a point-of care diagnostic tool for Onchocerciasis, commonly known as river blindness. It is the first in a suite of diagnostic innovations by PATH intended to support the elimination of neglected tropical diseases, a group of illnesses that affect more than a billion people worldwide.
The Bill & Melinda Gates Foundation

Contact: Kate Davidson

Public Release: 31-Oct-2014
New step towards eradication of H5N1 bird flu
A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or 'bird flu' with those that have been naturally infected.

Contact: Dr. Farhid Hemmatzadeh
University of Adelaide

Public Release: 30-Oct-2014
Technology and Innovation
Patents for humanity: Special edition of Technology and Innovation
The current special issue of Technology and Innovation is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. It includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs.

Contact: Diana Vergara
University of South Florida (USF Innovation)

Showing releases 976-1000 out of 1244.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>